AltabaxActive Ingredient(s): Retapamulin
FDA Approved: * April 12, 2007
Pharm Company: * GLAXO GRP LTD
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo. Retapamulin was approved by the United States Food and Drug Administration in April 2007 for the treatment of bacterial skin infections such as impetigo. In May 2007, retapamulin received approval in the EU from the European Medicines Agency for the same indi... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Altabax 10 mg/g Topical OintmentNDC: 0007-5180
Altabax 10 mg Topical OintmentNDC: 16110-518
Altabax 10 mg/g Topical OintmentNDC: 21695-644
Rebel Distributors Corp.
Altabax 10 mg/g Topical OintmentNDC: 54868-6096
Physicians Total Care, Inc.